Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls

Background: Heart failure with preserved ejection fraction (HFpEF) remains an ongoing therapeutic and diagnostic challenge to date. In this study we aimed for an analysis of the diagnostic potential of four novel cardiovascular biomarkers, GDF-15, H-FABP, sST2, and suPAR in HFpEF patients compared t...

Full description

Bibliographic Details
Main Authors: Peter Jirak, Rudin Pistulli, Michael Lichtenauer, Bernhard Wernly, Vera Paar, Lukas J. Motloch, Richard Rezar, Christian Jung, Uta C. Hoppe, P. Christian Schulze, Daniel Kretzschmar, Rüdiger C. Braun-Dullaeus, Tarek Bekfani
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
HFpEF
heart failure
HFrEF
biomarker
sST2
suPAR
Online Access:https://www.mdpi.com/2077-0383/9/4/1130

Internet

https://www.mdpi.com/2077-0383/9/4/1130

Similar Items